Cardiovascular Risk Beyond Low-Density Lipoprotein Cholesterol

被引：8
|
作者：
Mayr, Manuel [1 ]
Gerszten, Robert [2 ,3 ]
Kiechl, Stefan [4 ]
机构：
[1] Kings Coll London, Kings British Heart Fdn Ctr, 125 Coldharbour Lane, London SE5 9NU, England
[2] Beth Israel Deaconess Med Ctr, Div Pulm Crit Care & Sleep Med, Boston, MA 02215 USA
[3] Beth Israel Deaconess Med Ctr, Div Cardiovasc Med, Boston, MA 02215 USA
[4] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2018年 / 71卷 / 06期
基金：
美国国家卫生研究院;
关键词：
apolipoproteins; biomarkers; mass spectrometry; nuclear magnetic resonance spectroscopy; precision medicine; INTRACEREBRAL HEMORRHAGE; VULNERABLE PLAQUE; DISEASE RISK; METABOLOMICS; EPIDEMIOLOGY; EFFICACY; GENETICS; BRUNECK; STATINS; EVENTS;
D O I：
10.1016/j.jacc.2017.12.040
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：633 / 635
页数：3
相关论文
共 50 条
  • [31] Visit-to-Visit Low-Density Lipoprotein Cholesterol Variability and Risk of Cardiovascular Outcomes
    Bangalore, Sripal
    Breazna, Andrei
    DeMicco, David A.
    Wun, Chuan-Chuan
    Messerli, Franz H.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (15) : 1539 - 1548
  • [32] Low-density lipoprotein cholesterol and cardiovascular risk: a necessary causal agent but an insufficient predictor
    Tsaban, Gal
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (03) : E125 - E127
  • [33] The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
    Hu, Xiangming
    Liu, Qunzhi
    Guo, Xingyuan
    Wang, Weimian
    Yu, Bingyan
    Liang, Beijia
    Zhou, Yingling
    Dong, Haojian
    Lin, Jijin
    CARDIOVASCULAR DIABETOLOGY, 2022, 21 (01)
  • [34] The role of remnant cholesterol beyond low-density lipoprotein cholesterol in diabetes mellitus
    Xiangming Hu
    Qunzhi Liu
    Xingyuan Guo
    Weimian Wang
    Bingyan Yu
    Beijia Liang
    Yingling Zhou
    Haojian Dong
    Jijin Lin
    Cardiovascular Diabetology, 21
  • [35] From remnant cholesterol to lipoprotein(a) - emerging risk factors for cardiovascular diseases beyond low density lipoprotein
    Mukherjee, Debabrata
    Mikhailidis, Dimitri P.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (04)
  • [36] Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol
    Moriyama, Kengo
    Takahashi, Eiko
    CLINICAL LABORATORY, 2017, 63 (7-8) : 1179 - 1186
  • [37] Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care
    Bilgic, Selin
    Sniderman, Allan D.
    CURRENT OPINION IN CARDIOLOGY, 2024, 39 (01) : 49 - 53
  • [38] Beyond low-density lipoprotein cholesterol - A perspective on low high-density lipoprotein disorders and Lp(a) lipoprotein excess
    Rosenson, RS
    ARCHIVES OF INTERNAL MEDICINE, 1996, 156 (12) : 1278 - 1284
  • [39] Low-density lipoprotein size and cardiovascular risk assessment
    Rizzo, M
    Berneis, K
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2006, 99 (01) : 1 - 14
  • [40] Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
    Katsiki, Niki
    Vrablik, Michal
    Banach, Maciej
    Gouni-Berthold, Ioanna
    PHARMACEUTICALS, 2023, 16 (04)
12345